We are grateful to the Alzheimer’s Society Scottish Doctoral Training Centre and the RS Macdonald Trust Transition Fund for funding the research presented.Peer reviewedPublisher PD
Lipids are key regulators of brain function and have been increasingly implicated in neurodegenerati...
Abstract Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by the accumulation ...
Disturbances in cerebral cholesterol metabolism have been implicated in the pathogenesis of Alzheime...
BackgroundLipid dysregulation is associated with several key characteristics of Alzheimer’s disease ...
Acknowledgements The authors thank S. Tammireddy (Diabetes and Cardiovascular Science, University of...
Acknowledgements The authors thank S. Tammireddy (Diabetes and Cardiovascular Science, University of...
Alzheimer’s disease (AD) is a neurodegenerative disorder that causes severe and progressive cognitiv...
Alzheimer's disease (AD) is the leading cause of dementia in the elderly. Mutations in genes encodin...
Funding This work was supported by ARUK Project Grant PG2017B-11. Acknowledgements The authors would...
Processing of the amyloid precursor protein (APP) and amyloid beta (A beta) has been for decades in ...
Lipids are key regulators of brain function and have been increasingly implicated in neurodegenerati...
Apolipoprotein E ε4 (APOE4) is the primary genetic risk factor for the late-onset form of Alzheimer'...
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the most common cause of de...
Alzheimer’s disease (AD) is a chronic neurodegenerative disease that accounts for most cases of deme...
WOS: 000253935100002PubMed ID: 18288926Advances in Alzheimer Disease (AD) research suggest that cent...
Lipids are key regulators of brain function and have been increasingly implicated in neurodegenerati...
Abstract Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by the accumulation ...
Disturbances in cerebral cholesterol metabolism have been implicated in the pathogenesis of Alzheime...
BackgroundLipid dysregulation is associated with several key characteristics of Alzheimer’s disease ...
Acknowledgements The authors thank S. Tammireddy (Diabetes and Cardiovascular Science, University of...
Acknowledgements The authors thank S. Tammireddy (Diabetes and Cardiovascular Science, University of...
Alzheimer’s disease (AD) is a neurodegenerative disorder that causes severe and progressive cognitiv...
Alzheimer's disease (AD) is the leading cause of dementia in the elderly. Mutations in genes encodin...
Funding This work was supported by ARUK Project Grant PG2017B-11. Acknowledgements The authors would...
Processing of the amyloid precursor protein (APP) and amyloid beta (A beta) has been for decades in ...
Lipids are key regulators of brain function and have been increasingly implicated in neurodegenerati...
Apolipoprotein E ε4 (APOE4) is the primary genetic risk factor for the late-onset form of Alzheimer'...
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the most common cause of de...
Alzheimer’s disease (AD) is a chronic neurodegenerative disease that accounts for most cases of deme...
WOS: 000253935100002PubMed ID: 18288926Advances in Alzheimer Disease (AD) research suggest that cent...
Lipids are key regulators of brain function and have been increasingly implicated in neurodegenerati...
Abstract Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by the accumulation ...
Disturbances in cerebral cholesterol metabolism have been implicated in the pathogenesis of Alzheime...
DOI
Add to ORKG